CENTRAL SEROUS CHORIORETINOPATHY

This adverse event was reported 683 times

CENTRAL SEROUS CHORIORETINOPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BEVACIZUMAB-MALY 1 0.0050
1 SELUMETINIB 6 0.0036
2 PEMIGATINIB 3 0.0035
3 TESTOSTERONE UNDECANOATE 6 0.0031
4 TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% 71 0.0029
5 ERDAFITINIB 3 0.0024
6 TRIAMCINOLONE ACETONIDE 71 0.0022
7 TESTOSTERONE 47 0.0020
8 BINIMETINIB 15 0.0019
9 PREDNISOLONE SODIUM PHOSPHATE 4 0.0016
See all drugs enriched for association with CENTRAL SEROUS CHORIORETINOPATHY